Navigation Links
Study Shows Pine Bark Naturally Reduces Cardiovascular Risk Factors in Diabetics
Date:5/28/2008

Pycnogenol(R) improved diabetes control and reduced antihypertensive

medications

HOBOKEN, N.J., May 28 /PRNewswire/ -- A new study published in the May 2008 (volume 8, issue 25) edition of the journal of Nutrition Research shows Pycnogenol(R) (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, reduces blood sugar in type II diabetes patients, allows people to lower their antihypertensive medication and improves cardiovascular disease (CVD) risk factors. The study, conducted at the University of Arizona, Tucson, indicates Pycnogenol(R) may serve as a potent adjunct to prescription medications for the 20 million people in the Unites States living with diabetes.

"Most people with type II diabetes have cholesterol problems and half of those people experience hypertension. It has been documented that Pycnogenol(R) mediates a number of beneficial effects on the cardiovascular system for diabetics and healthy individuals," said Dr. Ronald Watson, a lead researcher of the study. "Previous studies have shown Pycnogenol(R) supplementation to be associated with reducing platelet aggregation, lowering LDL and increasing HDL cholesterol and modifying hypertension, among others. But what really makes the study results compelling is Pycnogenol(R) simultaneously lowered blood glucose, LDL cholesterol and blood pressure in patients. Furthermore, this is the first study suggesting that Pycnogenol(R) might also be beneficial in protecting kidney function in diabetics."

The 12-week, randomized, double-blind, placebo-controlled trial consisted of 48 men and women, 40 to 75 years of age, with noninsulin-dependent type II diabetes, taking anti-diabetic medication with metformin, sulfonylurea and glitazones. Furthermore, they took antihypertensive medications with ACE inhibitors such as Lisinopril. Despite their medication their fasting blood sugar was above healthy values (142 mg/dL) a
'/>"/>

SOURCE Natural Health Science
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer
2. Global study reveals differences in standard of care for osteoporosis across the world
3. New study shows positive role physical therapists play in lymphedema diagnois and treatment
4. RTOG Study Likely Treatment Option for Brain Tumor Patients like Sen. Kennedy
5. New CDC Study Shows Smoke-Free Laws Spreading Across U.S. and Should Spur Remaining States to Take Action
6. Experimental agent blocks prostate cancer in animal study
7. Study finds unique HIV vaccine formula elicits strong immune responses
8. First of its kind study compares high school knee injuries by sport and gender
9. UNC study firms up promise of potential new cervical cancer screening tool
10. Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50
11. Study presented at DDW 2008 Confirms that New Device Significantly Improves Detection of Polyps in the Colon

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ADELPHIA, Dec. 2 Independence Blue...ts contract with Lincoln Financial Group. IBC will...pproximately 10,000 Lincoln Financial Group employ...ion. The Lincoln plan offerings will include the P..., "I know I speak for all of us at Independence...
(Date:12/2/2009)...ph Balboni loves sports. An avid tennis player and...insurance agent became increasingly frustrated ove...a degenerative eye disorder. Unable to return the ...faced the prospect of a corneal transplant to rest...rs ago, Balboni discovered an alternative treatmen...
(Date:12/2/2009)... National Pen ( www.pens.com ), a worldwid... today it is giving away 10,000 free business card... 2, 2009 -- National Pen ( www.pens.com ), a world...ed today it is giving away 10,000 free business ca...mote business that no other company in the industr...
(Date:12/2/2009)... On Sunday, more than 900 runners and walk...ss the finish line at the Rock ‘n’ Rol...aising over $3.2 million for the Crohn,s & Col... program, Team Challenge (www.ccteamchallenge). As...go toward research, education, and support initiat...
(Date:12/2/2009)...SHINGTON, Dec. 2 Pro-ab...y, December 2 in their campaign against the U.S. H..., Americans United for Life President and CEO Char... the abortion lobby,s effort to expand taxpayer fu...th health care, the feminist groups and the aborti...
Breaking Medicine News(10 mins):Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 3Health News:Brandeis studies evaluate visionary approach to improving eyesight 2Health News:National Pen Giving Away 10,000 Business Card Pens 2Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 2Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 3Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 4
...s Leading Employers Adopts InterviewDirect to ... Positions, CHERRY HILL, N.J., Oct. 22 Trend Int...based job candidate screening solutions,today anno...viewDirect eliminates the historical inefficiencie...
..., Oct. 22 Science,Applications International Corp...ed an agreement with the University of Kent on beh...BI) to collaborate on biometric and,identity proje...llaborative research and development. One facet of...
...07)Work done in part by researchers at The Univers...the discovery of two genes that cause ankylosing s...ing disease. The findings are published in the Oc... M.D., professor and director of the Division of R...
... survival for elderly patients with lung cancer ha...care expenditures for lung cancer treatment. The s...ute, and National Bureau of Economic Research rese... rose by less than one month between 1983 and 1997...
...n, other injuries at bay, experts say , , ...fety measures can help ensure that Halloween is a ...xperts at Prevent Blindness America, a nonprofit ...e president, said in a prepared statement. "Our vi...
...eight years of planning and,preparation culminated...the,existing facility into the new state-of-the-ar...quare foot hospital brings together comprehensive ...bstetrics, the hospital offers care tailored to th...
Other Medicine News:Health News:Albert Einstein Healthcare Network Turns to InterviewDirect to Qualify Job Candidates 2Health News:Albert Einstein Healthcare Network Turns to InterviewDirect to Qualify Job Candidates 3Health News:SAIC to Collaborate with UK Biometrics Institute 2Health News:SAIC to Collaborate with UK Biometrics Institute 3Health News:UT rheumatologists discover 2 genes related to disabling form of arthritis 2Health News:UT rheumatologists discover 2 genes related to disabling form of arthritis 3Health News:Spending more for lung cancer treatment did not substantially increase patients' lives 2Health News:Eye on Safety Makes Halloween Less Scary 2Health News:Northwestern Memorial Hospital Completes Move Into Its New Prentice Women's Hospital 2Health News:Northwestern Memorial Hospital Completes Move Into Its New Prentice Women's Hospital 3
(Date:12/2/2009)... 2 Keryx Biopharmaceutic...e U.S. Food and Drug Administration (FDA) has gran...e), the Company,s novel, potentially first-in-clas...oinositide 3-kinase (PI3K)/Akt pathway, for the tr... ,, The Fast Track program of the FDA is design...
(Date:12/2/2009)...., Dec. 2 Roche (SIX: RO...ed States Food & Drug Administration (FDA) app...nucleic acid test, to screen source plasma in pool...test, called the cobas® TaqScreen MPX Test fo...e, in-vitro test for the simultaneous, direct dete...
(Date:12/2/2009)...ember 2 Amsterdam Molecu...field of human gene therapy,announced today a num...as,been appointed Chief Financial Officer, effecti... Director Process Development & Manufacturing,...d Project Management, also,effective December 1. T...
Breaking Medicine Technology:Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3AMT Announces Management Changes in Light of Refocused Strategy 2AMT Announces Management Changes in Light of Refocused Strategy 3Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 1Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 2Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 3Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 4SimplyAgeless Believes Michael Jackson Could Have Been Going Through Male Menopause 53710 1SimplyAgeless Believes Michael Jackson Could Have Been Going Through Male Menopause 53710 2Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results 13380 1Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results 13380 2Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results 13380 3Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results 13380 4Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results 13380 5Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results 13380 6
STAARVISC II
...igned with optimum molecular weight and viscosity,...ts and protects the delicate structures of the eye..., adhesion, and pseudoplasticity to satisfy all th...ts from an ophthalmic viscoelastic device. , ,...
...m Hyaluronate (1.8%) viscoelastic solution combine...use. Rayflo maintains a deep anterior chamber and ...y. It is ideal for routine cataract surgery but ca...a viscoelastic. Combine all these properties with ...
...terile, non-pyrogenic, transparent viscoelastic pr...igh molecular weight (average molecular weight 4 m... mg/mL of sodium hyaluronate 5000, dissolved in re...and sodium glucuronate linked by glycosidic bonds....
Medicine Products: